AUA and SUO publish guideline regarding early detection of prostate cancer | Hormone treatment for biochemical recurrence following definitive therapy of prostate cancer | World-famous surgical museum reopens following multimillion pound renovationPROSTATE cancer...
14. For patients with unfavorable intermediate- or high-risk prostate cancer and estimated life expectancy greater than 10 years, clinicians should offer a choice between radical prostatectomy or radiation therapy plus androgen deprivation therapy (AD...
参考文献: [1]Morgan TM, Boorjian SA, Buyyounouski MK, et al. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part I: introduction and treatment decision-making at the time of suspected biochemical recurrence after...
treated. As medical knowledge expands and technology advances, the guidelines will change. Today these evidence-based guidelines statements represent not absolute mandates but provisional proposals for treatment under the specific conditions described in each document. For all these reasons, the guidelines ...
内容提示: UNCORRECTED PROOFSalvage Therapy for Prostate Cancer: AUA/ASTRO/SUOGuideline Part I: Introduction and TreatmentDecision-Making at the Time of Suspected BiochemicalRecurrence after Radical ProstatectomyTodd M. Morgan, 1 Stephen A. Boorjian, 2 Mark K. Buyyounouski, 3 Brian F. Chapin, 4...
英文标题:Adjuvant Targeted Drug Therapy in Preventing Recurrence of High-Risk Renal Cancer Post-Surgery:A Systemic Review and Meta Analysis 中文标题:靶向药物辅助治疗预防高危肾癌术后复发:系统评价和荟萃分析 地点:221C 讲者:Yuzhe Tang 摘要号:PD09-01 ...
[1] Giorgio Gandaglia, et al. PD60-10 A More Extended Pelvic Lymph Node Dissection Decreases Recurrence Rates In Selected Prostate Cancer Patients Undergoing Radical Prostatectomy. Presented at: AUA 2022. The Journal of Urology, Volume 207 Issue Supplement 5, Page: e1029. May 2022. ...
UGN-101 showed efficacy in a broad population of patients with upper tract urothelial cancer and recurrence-free survival rates were high among patients who responded to UGN-101 induction therapy. Dr. Li on the design of the phase 3 MoonRISe-1 trial in NMIBC Urology Times staff May 6th 2024...
The 4Kscore maintains good discrimination for risk of high-grade prostate cancer in a subpopulation of men with PSA ≤4.0 ng/mL, with a sensitivity of 95% and a specificity of 56%. Homogeneous PTEN loss is associated with decreased time to biochemical recurrence; this effect is much stronger...
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Pr... The summary presented herein covers recommendations on salvage therapy for recurrent prostate cancer intended to facilitate care decisions and aid...